Recalcitrant cutaneous sarcoidosis responding to infliximab [7]

Archives of Dermatology

Volumn 141, Issue 7, 2005, Pages 910-911

  Heffernan, Michael P ^a   Anadkat, Milan J ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; CHLOROQUINE; CORTICOSTEROID; INFLIXIMAB; METHOTREXATE; MINOCYCLINE; THALIDOMIDE;

ADULT; ANAMNESIS; CASE REPORT; CATARACT; CLINICAL EXAMINATION; DISEASE DURATION; DRUG EFFICACY; DRUG RESPONSE; DYSPNEA; FEMALE; HUMAN; HYPERPIGMENTATION; LABORATORY TEST; LETTER; LEUKOPENIA; PAPULE; PRIORITY JOURNAL; PRURITUS; RADIODIAGNOSIS; SARCOIDOSIS; SIDE EFFECT; SYMPTOM; TREATMENT FAILURE; WEIGHT GAIN;

ANTIBODIES, MONOCLONAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; MIDDLE AGED; SARCOIDOSIS; SEVERITY OF ILLNESS INDEX; SKIN DISEASES; TREATMENT OUTCOME;

EID: 23044449073     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.141.7.910     Document Type: Letter

References (5)

1. Sharma OP. Sarcoidosis of the skin. In: Freedberg IM, Eisen AZ, eds. Fitzpatrick's Dermatology in General Medicine. 5th ed. New York, NY: McGraw-Hill; 1999:2099-2106.
2. Moller DR. Treatment of sarcoidosis-from a basic science point of view. J Intern Med. 2003;253:31-40.
3. Mallbris L, Ljungberg A, Hedblad MA, Larsson P, Stahle-Backdahl M. Progressive cutaneous sarcoidosis responding to anti-tumor necrosis factor-alpha therapy. J Am Acad Dermatol. 2003;48:290-293.
4. Haley H, Cantrell W, Smith K. Infliximab therapy for sarcoidosis (lupus pernio). Br J Dermatol. 2004;150:146-149.
5. Mohan N, Edwards ET, Cupps TR, et al. Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. Arthritis Rheum. 2001;44:2862-2869.